+76.7%
GSK vs MDY
+177.2%
-100.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MDY | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.8% | -0.8% | -0.3% |
| 7D | -3.5% | -1.9% | -1.7% | -2.8% |
| 30D | -3.4% | -4.6% | +1.2% | -1.7% |
| 3M | -8.1% | -1.2% | -6.9% | -7.8% |
| 6M | -11.1% | +9.2% | -20.3% | -14.2% |
| YTD | +0.7% | +13.1% | -12.3% | -4.0% |
| 1Y | +20.1% | +13.0% | +7.1% | +14.3% |
| 3Y | +46.1% | +49.2% | -3.1% | +23.1% |
| 5Y | +48.2% | +47.2% | +1.0% | +23.4% |
| All | +76.7% | +177.2% | -100.4% | +6.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MDY.
Daily Out/Under-Performance
Portfolio return minus MDY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MDY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MDY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling